Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ACHN

Achillion Pharmaceuticals (ACHN)

Achillion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACHN
DateTimeSourceHeadlineSymbolCompany
02/14/20204:55PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/14/20201:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/12/202010:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/12/20207:58AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/10/20207:34AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/07/20206:11AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/03/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/03/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/03/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
02/03/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
12/19/20199:24AMGlobeNewswire Inc.Achillion Shareholders Approve Agreement to be Acquired by AlexionNASDAQ:ACHNAchillion Pharmaceuticals Inc
12/09/201910:00AMGlobeNewswire Inc.Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/22/201910:42AMPR Newswire (US)Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/19/20197:30AMGlobeNewswire Inc.European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/11/20197:30AMGlobeNewswire Inc.Achillion Announces Clearance of Investigational New Drug Application for ACH-5228NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/07/20194:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/07/20194:18PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/07/20194:08PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/07/20197:30AMGlobeNewswire Inc.Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
11/06/20199:07AMGlobeNewswire Inc.Achillion Announces Data Presentations at the 61st American Society of Hematology Annual MeetingNASDAQ:ACHNAchillion Pharmaceuticals Inc
11/05/20195:07PMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/01/20194:23PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/18/20195:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/18/20194:50PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/17/20195:09PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/16/20194:55PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/16/201910:44AMPR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/16/20198:54AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/16/20198:52AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
10/16/20198:50AMPR Newswire (US)Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...NASDAQ:ACHNAchillion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACHN